Daiichi Sankyo U.S. CEO Joe Pieroni: An Interview With “The Pink Sheet” DAILY (Part 1 of 2)

Exec discusses the merger of Daiichi and Sankyo, how the combined entity has evolved, and how the firm's Benicar/amlodipine combination Azor figures as a key growth driver going forward.